Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.22) per share. This is a 12 percent increase over losses of $(0.25) per share from the same period last year.
Related Posts
PennantPark Floating Rate Capital Ltd. Priced 4M Share Public Offering of Common Stock @$12.40/Share
PennantPark Floating Rate Capital Ltd.
Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs
Challenges and updates in the weight loss drug market, as Novo Nordisk and Eli Lilly address supply shortages for Wegovy and Mounjaro. Strategies to meet the increasing demand and potential market projections.
Why AdaptHealth Stock Trading Is Lower Today
AdaptHealth Corp (NASDAQ: AHCO) reported third-quarter net revenue of $804.0 million, up 6.3% Y/Y, beating the